COVID-19 in children ranging from asymptomatic to a multi-system inflammatory disease

References

1. 1.↵
   1. Li W,
   2. Cui H,
   3. Li K,
   4. Fang Y,
   5. Li S.

   Chest computed tomography in children with COVID-19 respiratory infection. Pediatr Radiol 2020; 50: 796–799.

   OpenUrl
2. 2.↵
   1. Ludvigsson JF.

   Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020; 109:1088–1095.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Balasubramanian S,
   2. Rao NM,
   3. Goenka A,
   4. Roderick M,
   5. Ramanan AV.

   Coronavirus Disease 2019 (COVID-19) in Children - What We Know So Far and What We Do Not. Indian Pediatr 2020; 57: 435–442.

   OpenUrl
4. 4.↵
   1. De Souza TH,
   2. Nadal JA,
   3. Nogueira RJN,
   4. Pereira RM,
   5. Brandão MB.

   Clinical manifestations of children with COVID-19: A systematic review. Pediatric Pulmonology 2020; 55: 1892–1899.

   OpenUrlCrossRefPubMed
5. 5.↵
   Saudi center for Disease Control and Prevention. Available at: https://covid19.cdc.gov.sa/. Cited Jun 10,2020
6. 6.↵
   1. Ye Q,
   2. Wang B,
   3. Mao J.

   The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect 2020; 80: 607–613.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Cruz AT,
   2. Zeichner SL.

   COVID-19 in Children: Initial Characterization of the Pediatric Disease. Pediatrics 2020; 145: e20200834.

   OpenUrlFREE Full Text
8. 8.↵
   1. Dong Y,
   2. Mo X,
   3. Hu Y,
   4. Qi X,
   5. Jiang F,
   6. Jiang Z, et al.

   Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020; 145: e20200702.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   Centers for Disease Control and Prevention. Kawasaki Disease [Updated 2018 October 24; Accessed 2020 September 8]. Available from: https://www.cdc.gov/kawasaki/case-definition.html
10. 10.↵
    1. Jones VG,
    2. Mills M,
    3. Suarez D,
    4. Hogan CA,
    5. Yeh D,
    6. Segal JB, et al.

    COVID-19 and Kawasaki Disease: Novel virus and novel case. Hosp Pediatr 2020; 10: 537–540.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Kim YJ,
    2. Park H,
    3. Choi YY,
    4. Kim YK,
    5. Yoon Y,
    6. Kim KR, et al.

    Defining Association between COVID-19 and the Multisystem inflammatory syndrome in children through the pandemic. J Korean Med Sci 2020; 35: e204.

    OpenUrl
12. 12.↵
    1. Mei-Jy J.

    Coronavirus disease 2019 in children: Current status. J Chin Med Assoc 2020; 83: 527–533.

    OpenUrlCrossRef
13. 13.↵
    1. Sun D,
    2. Li H,
    3. Lu XX,
    4. Xiao H,
    5. Ren J,
    6. Zhang F, et al.

    Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study. World J Pediatr 2020; 16: 251–259.

    OpenUrlPubMed
14. 14.↵
    1. Henry BM,
    2. Lippi G,
    3. Plebani M.

    Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med 2020; 58: 1135–1138.

    OpenUrl
15. 15.↵
    1. Zhang L,
    2. Yan X,
    3. Fan Q,
    4. Liu H,
    5. Liu X,
    6. Liu Z, et al.

    D-dimer levels on admission to predict in hospital mortality in patients with Covid-19. J Thromb Haemost 2020; 18: 1324–1329.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Tang N,
    2. Li D,
    3. Wang X,
    4. Sun Z.

    Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18: 844–847.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Misra M,
    2. Pacaud D,
    3. Petryk A,
    4. Collett-Solberg PF,
    5. Kappy M.

    Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008; 122: 398–417.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Martineau AR and
    2. Forouhi NG.

    Vitamin D for COVID-19: a case to answer? Lancet Diabetes Endocrinol 2020; 8: 735–736.

    OpenUrl
19. 19.↵
    1. De Biasi RL,
    2. Song X,
    3. Delaney M,
    4. Bell M,
    5. Smith K,
    6. Pershad J, et al.

    Severe coronavirus disease-2019 in children and young adults in the Washington, DC, Metropolitan Region. J Pediatr 2020; 223: 199–203.e1.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Loi M,
    2. Branchford B,
    3. Kim J,
    4. Self C,
    5. Nuss R.

    COVID-19 anticoagulation recommendations in children. Pediatr Blood Cancer 2020; 67: e28485.

    OpenUrl
21. 21.↵
    1. Verdoni L,
    2. Mazza A,
    3. Gervasoni A,
    4. Martelli L,
    5. Ruggeri M,
    6. Ciuffreda M, et al.

    An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395: 1771–1778.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Hennon TR,
    2. Penque MD,
    3. Abdul-Aziz R,
    4. Alibrahim OS,
    5. McGreevy MB,
    6. Prout AJ,et al.

    COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach. Prog Pediatr Cardiol. 2020; 23: 101232.

    OpenUrl